跳至主要内容
临床试验/NCT06164236
NCT06164236已完成不适用

Study of Predictors of Failure of Sulprostone Treatment in Postpartum Hemorrhage

University Hospital, Strasbourg, France1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2020年10月19日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
300
试验地点
1
主要终点
This a rétrospective study trayning to identify a potential predictors of failure of second-line drug treatment in the case of severe postpartum hemorrhage

研究概览

简要总结

The investigators wish to identify potential factors predicting failure of second-line drug treatment (sulproston (Nalador®)): risk factors and factors linked to a failure to take initial care for PPH.

A better understanding of the aggravating factors of HPP and more particularly the factors inherent to the initial care would make it possible to think of ways to improve practices.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Major subject (≥18 years old)
  • Subject having given birth at HUS or CHU Poissy Saint-Germain-en Laye between 01/01/2019 and 31/12/2020
  • Subject having presented a postpartum haemorrhage treated with Sulprostone
  • Subject not having expressed his opposition, after information, to the reuse of his data for the purposes of this research

排除标准

  • Subject having expressed opposition to participating in the study
  • Subject under guardianship or guardianship
  • Subject under safeguard of justice

结局指标

主要结局

This a rétrospective study trayning to identify a potential predictors of failure of second-line drug treatment in the case of severe postpartum hemorrhage

时间窗: 1 year

次要结局

未报告次要终点

研究者

发起方
University Hospital, Strasbourg, France
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验